Results 1 to 4 of about 4 (4)
Benchmarking tocilizumab use for giant cell arteritis. [PDF]
Rheumatol Adv Pract, 2022 Conway R, Putman MS, Mackie SL.
europepmc +1 more source
Tocilizumab for relapsing and remitting giant cell arteritis: a case series. [PDF]
J Med Case Rep, 2022 Saha P +3 more
europepmc +1 more source
Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. [PDF]
Mol Cell Biol, 2002 Ghioni P +5 more
europepmc +1 more source
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment. [PDF]
Rheumatol Adv PractQuick V, Benson F, Mackie SL.
europepmc +1 more source